Im Cannabis Corp Net Income
| IMCC Stock | USD 0.68 0.04 5.56% |
As of the 28th of February, Im Cannabis owns the Information Ratio of (0.15), market risk adjusted performance of (0.42), and Coefficient Of Variation of (744.92). Im Cannabis Corp technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices.
Im Cannabis Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.3881 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -10.6 M | -11.1 M | |
| Net Loss | -10.6 M | -11.1 M | |
| Net Loss | -16 M | -16.8 M | |
| Net Loss | (4.06) | (4.26) | |
| Net Income Per E B T | 0.74 | 0.71 |
IMCC | Net Income | Build AI portfolio with IMCC Stock |
Analyzing Im Cannabis's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Im Cannabis's current valuation and future prospects.
Latest Im Cannabis' Net Income Growth Pattern
Below is the plot of the Net Income of Im Cannabis Corp over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Im Cannabis Corp financial statement analysis. It represents the amount of money remaining after all of Im Cannabis Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Im Cannabis' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Im Cannabis' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (11.77 M) | 10 Years Trend |
|
Net Income |
| Timeline |
IMCC Net Income Regression Statistics
| Arithmetic Mean | (16,930,498) | |
| Geometric Mean | 1,800,625 | |
| Coefficient Of Variation | (265.89) | |
| Mean Deviation | 21,712,883 | |
| Median | (5,374,000) | |
| Standard Deviation | 45,017,166 | |
| Sample Variance | 2026.5T | |
| Range | 190.6M | |
| R-Value | (0.30) | |
| Mean Square Error | 1968.7T | |
| R-Squared | 0.09 | |
| Significance | 0.24 | |
| Slope | (2,663,179) | |
| Total Sum of Squares | 32424.7T |
IMCC Net Income History
Other Fundumenentals of Im Cannabis Corp
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Im Cannabis Net Income component correlations
IMCC Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Im Cannabis is extremely important. It helps to project a fair market value of IMCC Stock properly, considering its historical fundamentals such as Net Income. Since Im Cannabis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Im Cannabis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Im Cannabis' interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could IMCC diversify its offerings? Factors like these will boost the valuation of Im Cannabis. Market participants price IMCC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Im Cannabis data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.50) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Understanding Im Cannabis Corp requires distinguishing between market price and book value, where the latter reflects IMCC's accounting equity. The concept of intrinsic value - what Im Cannabis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Im Cannabis' price substantially above or below its fundamental value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Im Cannabis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Im Cannabis 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Im Cannabis' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Im Cannabis.
| 11/30/2025 |
| 02/28/2026 |
If you would invest 0.00 in Im Cannabis on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding Im Cannabis Corp or generate 0.0% return on investment in Im Cannabis over 90 days. Im Cannabis is related to or competes with Akanda Corp, Redhill Biopharma, Shuttle Pharmaceuticals, Movano, Jaguar Animal, ENDRA Life, and Venus Concept. IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada More
Im Cannabis Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Im Cannabis' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Im Cannabis Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 35.18 | |||
| Value At Risk | (10.92) | |||
| Potential Upside | 11.39 |
Im Cannabis Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Im Cannabis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Im Cannabis' standard deviation. In reality, there are many statistical measures that can use Im Cannabis historical prices to predict the future Im Cannabis' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.97) | |||
| Total Risk Alpha | (1.45) | |||
| Treynor Ratio | (0.43) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Im Cannabis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Im Cannabis February 28, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.42) | |||
| Mean Deviation | 4.34 | |||
| Coefficient Of Variation | (744.92) | |||
| Standard Deviation | 6.02 | |||
| Variance | 36.25 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.97) | |||
| Total Risk Alpha | (1.45) | |||
| Treynor Ratio | (0.43) | |||
| Maximum Drawdown | 35.18 | |||
| Value At Risk | (10.92) | |||
| Potential Upside | 11.39 | |||
| Skewness | 0.1345 | |||
| Kurtosis | 1.7 |
Im Cannabis Corp Backtested Returns
Im Cannabis Corp retains Efficiency (Sharpe Ratio) of -0.25, which attests that the entity had a -0.25 % return per unit of price deviation over the last 3 months. Im Cannabis exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Im Cannabis' Coefficient Of Variation of (744.92), information ratio of (0.15), and Market Risk Adjusted Performance of (0.42) to validate the risk estimate we provide. The company owns a Beta (Systematic Risk) of 1.89, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Im Cannabis will likely underperform. At this point, Im Cannabis Corp has a negative expected return of -1.41%. Please make sure to check out Im Cannabis' potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if Im Cannabis Corp performance from the past will be repeated in the future.
Auto-correlation | 0.78 |
Good predictability
Im Cannabis Corp has good predictability. Overlapping area represents the amount of predictability between Im Cannabis time series from 30th of November 2025 to 14th of January 2026 and 14th of January 2026 to 28th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Im Cannabis Corp price movement. The serial correlation of 0.78 indicates that around 78.0% of current Im Cannabis price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.78 | |
| Spearman Rank Test | 0.84 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
IMCC Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Im Cannabis Corp reported net income of (11.77 Million). This is 103.45% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 102.06% higher than that of the company.
IMCC Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Im Cannabis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Im Cannabis could also be used in its relative valuation, which is a method of valuing Im Cannabis by comparing valuation metrics of similar companies.Im Cannabis is currently under evaluation in net income category among its peers.
Im Cannabis Institutional Holders
Institutional Holdings refers to the ownership stake in Im Cannabis that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Im Cannabis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Im Cannabis' value.| Shares | Bryn Mawr Trust Company | 2025-06-30 | 9.0 | Park Square Financial Group, Llc | 2025-06-30 | 3.0 | Ubs Group Ag | 2025-06-30 | 3.0 | Group One Trading, Lp | 2025-06-30 | 2.0 | Kiker Wealth Management, Llc | 2025-06-30 | 1.0 | Sbi Securities Co Ltd | 2025-06-30 | 0.0 | Advisorshares Investments, Llc | 2025-06-30 | 104.9 K | Heron Bay Capital Management | 2025-06-30 | 78.8 K | Citadel Advisors Llc | 2025-06-30 | 12.2 K | Bank Of Montreal | 2025-06-30 | 12.2 K | Bmo Capital Markets Corp. | 2025-06-30 | 12.2 K |
IMCC Fundamentals
| Return On Equity | -1.2 | ||||
| Return On Asset | -0.0672 | ||||
| Profit Margin | (0.09) % | ||||
| Operating Margin | (0.08) % | ||||
| Current Valuation | 14.87 M | ||||
| Shares Outstanding | 5.89 M | ||||
| Shares Owned By Insiders | 44.66 % | ||||
| Shares Owned By Institutions | 3.42 % | ||||
| Number Of Shares Shorted | 19.23 K | ||||
| Price To Book | 1.56 X | ||||
| Price To Sales | 0.08 X | ||||
| Revenue | 54.03 M | ||||
| Gross Profit | 12.28 M | ||||
| EBITDA | (6.14 M) | ||||
| Net Income | (11.77 M) | ||||
| Cash And Equivalents | 5.86 M | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 18.01 M | ||||
| Debt To Equity | 0.20 % | ||||
| Current Ratio | 1.18 X | ||||
| Book Value Per Share | 0.55 X | ||||
| Cash Flow From Operations | (1.08 M) | ||||
| Short Ratio | 0.35 X | ||||
| Earnings Per Share | (0.50) X | ||||
| Target Price | 8.22 | ||||
| Beta | 2.01 | ||||
| Market Capitalization | 4.01 M | ||||
| Total Asset | 39.19 M | ||||
| Retained Earnings | (258.94 M) | ||||
| Working Capital | (11.55 M) | ||||
| Net Asset | 39.19 M |
About Im Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Im Cannabis Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Im Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Im Cannabis Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Im Cannabis Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Im Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Im Cannabis Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Im Cannabis Corp Stock:Check out You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Will Biotechnology sector continue expanding? Could IMCC diversify its offerings? Factors like these will boost the valuation of Im Cannabis. Market participants price IMCC higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Im Cannabis data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.50) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Understanding Im Cannabis Corp requires distinguishing between market price and book value, where the latter reflects IMCC's accounting equity. The concept of intrinsic value - what Im Cannabis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Im Cannabis' price substantially above or below its fundamental value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Im Cannabis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.